Last --
Change Today 0.00 / 0.00%
Volume 0.0
4162 On Other Exchanges
Symbol
Exchange
4162 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Lin Rong-Jin

Founder and Chairman, PharmaEngine Inc.
AgeTotal Calculated CompensationThis person is connected to 32 board members in 2 different organizations across 2 different industries.

See Board Relationships
----

Background*

Mr. Lin Rong-Jin serves as the Chairman of the Board, Chief Executive Officer and President of TTY Biopharm Co. Ltd. Mr. Rong-Jin founded Pharmaengine Inc. and serves as its Chairman of the Board. He serves as a Director of Epitomics, Inc. He Graduated in Pharmacy from Taipei Medical university.

Corporate Headquarters*

237 Sung-Chiang Road
Taipei, -- 104

Taiwan

Phone: 886 2 2515 8228
Fax: 886 2 2515 7558

Board Members Memberships*

Director
Founder and Chairman

Education*

Unknown/Other Education
Taipei Medical University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4162:TT 268.50 TWD -19.50

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMAENGINE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.